-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Medical Network News on March 15
More high-value consumables are included in centralized procurement
On the evening of March 9, according to the official website of the State Council, Hu Jinglin, director of the National Medical Insurance Administration, published an article in the "Study Times" stating that we must overcome difficulties, find a fulcrum, and lead the medical reform to deepen with the "small incision and big reform" of medical insurance.
Among them, the first is the gradual normalization of centralized and quantity procurement, which effectively squeezes the water consumption of medicines, reduces the burden on the masses, purifies the ecology of the industry, and standardizes medical behavior.
According to reports, the three batches of state-organized centralized drug procurement cover a total of 112 varieties, with an average price reduction of 54%, and annual cost savings of 53.
9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
At the same time, the reform of high-value medical consumables will be taken care of, and the bonus of medical consumables will be cancelled.
The second is to continue to consolidate the high-pressure situation of fund supervision.
Since 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
Since 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
This year's government work report also mentioned that improving the mechanism of ensuring the supply and stabilizing the price of shortage of drugs, and adopting methods such as including more chronic diseases, common disease drugs and high-value medical consumables into centralized procurement, further significantly reduce the medical burden of patients.
It is understood that the current pressure on the revenue and expenditure of the National Medical Insurance Fund is increasing.
The above article shows that the international situation is turbulent, the international economic recovery is unstable and uneven, the domestic economy has shifted to medium-to-high-speed growth, and the impact of the epidemic is superimposed.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
At the same time, the ever-increasing number of patients with chronic diseases, the ever-increasing degree of aging, and the ever-improving medical technology are all stimulating the growth of medical consumption.
Irregular medical services, fraudulent insurance by various medical institutions, irregular use of medical insurance funds, high prices of medical supplies, and excessive diagnosis and treatment are still common.
The pressure on the balance of medical insurance funds continues to increase, which requires that the high-quality development of medical insurance must be promoted and the role of strategic purchase of medical insurance must be brought into full play.
In the next round, bargaining for orthopedic supplies?
On March 8, according to news from the Qingyuan Municipal People’s Congress website, Zhou Haibo, deputy to the National People’s Congress and Secretary of the Party Committee of Qingyuan People’s Hospital, analyzed according to the statistics of the top three hospitals in 2019, the actual medical expenses incurred by patients undergoing coronary intervention surgery averaged 56,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
In this way, the cost of high-value consumables accounts for about half of the entire hospitalization expenses.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
After the volume purchase, the price of coronary stents has dropped significantly.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Prior to this, on February 25, according to the Sichuan Medical Insurance Bureau, from February 22 to 23, Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Bureau, led a team to Sichuan Province to conduct research on the centralized procurement of high-value medical consumables.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
On February 26, according to the official micro-message of the National Medical Insurance Administration, from February 25 to 26, Chen Jinfu, a member of the Party Group and Deputy Director of the National Medical Insurance Administration, hosted a special seminar in Tianjin.
During this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
During this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
According to the data of China Industry Information Network, it is predicted that the global orthopedic implant consumables will reach 53 billion yuan in 2024, and the compound growth rate of 2016-2024 is estimated to be about 3%.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
According to the relevant research report of punctuation information, based on the statistical caliber of the product registration certificate, there are currently about 370 manufacturers in the domestic orthopedic medical device market, of which about 270 are domestic enterprises.
The overall competition pattern is relatively scattered.
The overall competition pattern is relatively scattered.
Looking at industry changes from the development direction of medical insurance
In the medical industry with three-medicine linkage, the first link of medicine belongs to the supplier, providing drugs and medical equipment, the hospital belongs to the provider of medical services, and the patient and medical insurance are the payers, and the medical insurance is responsible for most of the expenses as a whole.
Many hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Many hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Therefore, the development direction of medical insurance will directly affect the overall development direction of the industry.
Hu Jinglin published the above-mentioned article in the "Learning Times" and stated that to promote the high-quality development of medical insurance, this is a process from extensive expansionary development to quality and efficiency development.
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The first is to be more fair, emphasizing the promotion of common prosperity, so that all people can share the fruits of development;
The second is to be more efficient, emphasizing improving the efficiency of fund use, and attaching importance to the input-output ratio;
The third is more sustainable, emphasizing continuous and stable protection of the basic health rights of the people, and the system and funds can maintain their own balance in the medium and long term;
The fourth is to be more secure, emphasizing the positioning of the basic system of social security, safeguarding the fundamental interests of the broadest masses of people, coordinating the advancement of medical insurance and medical development, ensuring the safe operation of funds and timely payment of benefits, etc.
;
;
Fifth, it is more convenient, emphasizing reducing the waiting time and cost of mass business processing.
On March 8th, the National Medical Insurance Administration issued the "Statistical Bulletin of Medical Security Development in 2020".
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
Among them, the annual employee basic medical insurance fund income was 1,562.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
Researchers from the Chinese Academy of Labor and Social Security Sciences published an article analysis in "China Medical Insurance" that the income of the employee medical insurance fund fell by 1.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
The above-mentioned researchers further analyzed that in the past year, regardless of whether the employee medical insurance or the resident medical insurance, the growth of fund expenditures has shown a new situation that is very different from that of previous years.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
The slight increase or slight decrease in medical insurance fund expenditures in 2020 is closely related to the new crown epidemic greatly reducing the demand for medical treatment.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
This requires that the reform of medical insurance payment methods in the future still needs to be accelerated, and fund supervision needs to be strengthened to continue to squeeze out a large amount of medical expenses and further improve the efficiency of the use of medical insurance funds.
Medical Network News on March 15
More high-value consumables are included in centralized procurement
On the evening of March 9, according to the official website of the State Council, Hu Jinglin, director of the National Medical Insurance Administration, published an article in the "Study Times" stating that we must overcome difficulties, find a fulcrum, and lead the medical reform to deepen with the "small incision and big reform" of medical insurance.
Among them, the first is the gradual normalization of centralized and quantity procurement, which effectively squeezes the water consumption of medicines, reduces the burden on the masses, purifies the ecology of the industry, and standardizes medical behavior.
According to reports, the three batches of state-organized centralized drug procurement cover a total of 112 varieties, with an average price reduction of 54%, and annual cost savings of 53.
9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
At the same time, the reform of high-value medical consumables will be taken care of, and the bonus of medical consumables will be cancelled.
The second is to continue to consolidate the high-pressure situation of fund supervision.
Since 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
Since 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
This year's government work report also mentioned that improving the mechanism of ensuring the supply and stabilizing the price of shortage of drugs, and adopting methods such as including more chronic diseases, common disease drugs and high-value medical consumables into centralized procurement, further significantly reduce the medical burden of patients.
It is understood that the current pressure on the revenue and expenditure of the National Medical Insurance Fund is increasing.
The above article shows that the international situation is turbulent, the international economic recovery is unstable and uneven, the domestic economy has shifted to medium-to-high-speed growth, and the impact of the epidemic is superimposed.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
At the same time, the ever-increasing number of patients with chronic diseases, the ever-increasing degree of aging, and the ever-improving medical technology are all stimulating the growth of medical consumption.
Irregular medical services, fraudulent insurance by various medical institutions, irregular use of medical insurance funds, high prices of medical supplies, and excessive diagnosis and treatment are still common.
The pressure on the balance of medical insurance funds continues to increase, which requires that the high-quality development of medical insurance must be promoted and the role of strategic purchase of medical insurance must be brought into full play.
In the next round, bargaining for orthopedic supplies?
On March 8, according to news from the Qingyuan Municipal People’s Congress website, Zhou Haibo, deputy to the National People’s Congress and Secretary of the Party Committee of Qingyuan People’s Hospital, analyzed according to the statistics of the top three hospitals in 2019, the actual medical expenses incurred by patients undergoing coronary intervention surgery averaged 56,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
In this way, the cost of high-value consumables accounts for about half of the entire hospitalization expenses.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
After the volume purchase, the price of coronary stents has dropped significantly.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Prior to this, on February 25, according to the Sichuan Medical Insurance Bureau, from February 22 to 23, Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Bureau, led a team to Sichuan Province to conduct research on the centralized procurement of high-value medical consumables.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
On February 26, according to the official micro-message of the National Medical Insurance Administration, from February 25 to 26, Chen Jinfu, a member of the Party Group and Deputy Director of the National Medical Insurance Administration, hosted a special seminar in Tianjin.
During this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
During this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
According to the data of China Industry Information Network, it is predicted that the global orthopedic implant consumables will reach 53 billion yuan in 2024, and the compound growth rate of 2016-2024 is estimated to be about 3%.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
According to the relevant research report of punctuation information, based on the statistical caliber of the product registration certificate, there are currently about 370 manufacturers in the domestic orthopedic medical device market, of which about 270 are domestic enterprises.
The overall competition pattern is relatively scattered.
The overall competition pattern is relatively scattered.
Looking at industry changes from the development direction of medical insurance
In the medical industry with three-medicine linkage, the first link of medicine belongs to the supplier, providing drugs and medical equipment, the hospital belongs to the provider of medical services, and the patient and medical insurance are the payers, and the medical insurance is responsible for most of the expenses as a whole.
Many hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Many hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Therefore, the development direction of medical insurance will directly affect the overall development direction of the industry.
Hu Jinglin published the above-mentioned article in the "Learning Times" and stated that to promote the high-quality development of medical insurance, this is a process from extensive expansionary development to quality and efficiency development.
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The first is to be more fair, emphasizing the promotion of common prosperity, so that all people can share the fruits of development;
The second is to be more efficient, emphasizing improving the efficiency of fund use, and attaching importance to the input-output ratio;
The third is more sustainable, emphasizing continuous and stable protection of the basic health rights of the people, and the system and funds can maintain their own balance in the medium and long term;
The fourth is to be more secure, emphasizing the positioning of the basic system of social security, safeguarding the fundamental interests of the broadest masses of people, coordinating the advancement of medical insurance and medical development, ensuring the safe operation of funds and timely payment of benefits, etc.
;
;
Fifth, it is more convenient, emphasizing reducing the waiting time and cost of mass business processing.
On March 8th, the National Medical Insurance Administration issued the "Statistical Bulletin of Medical Security Development in 2020".
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
Among them, the annual employee basic medical insurance fund income was 1,562.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
Researchers from the Chinese Academy of Labor and Social Security Sciences published an article analysis in "China Medical Insurance" that the income of the employee medical insurance fund fell by 1.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
The above-mentioned researchers further analyzed that in the past year, regardless of whether the employee medical insurance or the resident medical insurance, the growth of fund expenditures has shown a new situation that is very different from that of previous years.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
The slight increase or slight decrease in medical insurance fund expenditures in 2020 is closely related to the new crown epidemic greatly reducing the demand for medical treatment.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
This requires that the reform of medical insurance payment methods in the future still needs to be accelerated, and fund supervision needs to be strengthened to continue to squeeze out a large amount of medical expenses and further improve the efficiency of the use of medical insurance funds.
Medical Network News on March 15
More high-value consumables are included in centralized procurement
More high-value consumables are included in centralized procurement On the evening of March 9, according to the official website of the State Council, Hu Jinglin, director of the National Medical Insurance Administration, published an article in the "Study Times" stating that we must overcome difficulties, find a fulcrum, and lead the medical reform to deepen with the "small incision and big reform" of medical insurance.
Among them, the first is the gradual normalization of centralized and quantity procurement, which effectively squeezes the water consumption of medicines, reduces the burden on the masses, purifies the ecology of the industry, and standardizes medical behavior.
According to reports, the three batches of state-organized centralized drug procurement cover a total of 112 varieties, with an average price reduction of 54%, and annual cost savings of 53.
9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
Medicine, medicine, medicine9 billion yuan.
For the first time the state organized the centralized procurement of high-value medical consumables, the price of selected coronary stents dropped by more than 90%, and it is estimated that the annual medical cost will be saved by 11.
7 billion yuan.
At the same time, the reform of high-value medical consumables will be taken care of, and the bonus of medical consumables will be cancelled.
The second is to continue to consolidate the high-pressure situation of fund supervision.
Since 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
Medicine Medicine MedicineSince 2018, a total of 730,000 medical institutions that violate laws and regulations have been investigated and dealt with , and 34.
87 billion yuan of medical insurance funds have been recovered.
The third is to continue to deepen the reform of payment methods, and to advance the DRG payment national pilot and DIP payment pilot in an orderly manner.
This year's government work report also mentioned that improving the mechanism of ensuring the supply and stabilizing the price of shortage of drugs, and adopting methods such as including more chronic diseases, common disease drugs and high-value medical consumables into centralized procurement, further significantly reduce the medical burden of patients.
It is understood that the current pressure on the revenue and expenditure of the National Medical Insurance Fund is increasing.
The above article shows that the international situation is turbulent, the international economic recovery is unstable and uneven, the domestic economy has shifted to medium-to-high-speed growth, and the impact of the epidemic is superimposed.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
The space for increasing medical insurance income by relying on increased financial investment and increased payment by enterprises and residents is gradually shrinking.
At the same time, the ever-increasing number of patients with chronic diseases, the ever-increasing degree of aging, and the ever-improving medical technology are all stimulating the growth of medical consumption.
Irregular medical services, fraudulent insurance by various medical institutions, irregular use of medical insurance funds, high prices of medical supplies, and excessive diagnosis and treatment are still common.
The pressure on the balance of medical insurance funds continues to increase, which requires that the high-quality development of medical insurance must be promoted and the role of strategic purchase of medical insurance must be brought into full play.
In the next round, bargaining for orthopedic supplies?
In the next round, bargaining for orthopedic supplies? On March 8, according to news from the Qingyuan Municipal People’s Congress website, Zhou Haibo, deputy to the National People’s Congress and Secretary of the Party Committee of Qingyuan People’s Hospital, analyzed according to the statistics of the top three hospitals in 2019, the actual medical expenses incurred by patients undergoing coronary intervention surgery averaged 56,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
Around, the coronary stent is about 16,000 yuan, and the other consumables are about 10,000 yuan.
In this way, the cost of high-value consumables accounts for about half of the entire hospitalization expenses.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
Even if the medical insurance reimbursement is finally reimbursed, the personal medical burden of employees will be about 15,000 yuan, and the personal burden of residents' medical treatment will be about 24,000 yuan.
After the volume purchase, the price of coronary stents has dropped significantly.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Zhou Haibo said that it is recommended to continue to accelerate the centralized volume purchase of high-value medical consumables such as orthopedics and other mature domestic substitutes.
Prior to this, on February 25, according to the Sichuan Medical Insurance Bureau, from February 22 to 23, Hu Jinglin, Secretary of the Party Leadership Group and Director of the National Medical Security Bureau, led a team to Sichuan Province to conduct research on the centralized procurement of high-value medical consumables.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
Hu Jinglin and his entourage listened to relevant opinions and suggestions on the collection of orthopedic consumables and oral consumables from West China Hospital of Sichuan University, Provincial Orthopedic Hospital, and West China Stomatological Hospital of Sichuan University.
On February 26, according to the official micro-message of the National Medical Insurance Administration, from February 25 to 26, Chen Jinfu, a member of the Party Group and Deputy Director of the National Medical Insurance Administration, hosted a special seminar in Tianjin.
During this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
Medical device medical device medical device enterprise enterprise enterpriseDuring this period, Chen Jinfu and his entourage conducted field investigations on the quality of medical devices in Tianjin.
The inspection center and Zhengtian Medical Devices Co.
, Ltd.
understand the production and circulation of orthopedic consumables and listen to the opinions and suggestions of enterprises .
According to the data of China Industry Information Network, it is predicted that the global orthopedic implant consumables will reach 53 billion yuan in 2024, and the compound growth rate of 2016-2024 is estimated to be about 3%.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
The global orthopedic consumables market is concentrated, with the top five companies Johnson & Johnson, Zimmer, Stryker, Medtronic and Xerox, accounting for approximately 62% of the global market share.
According to the relevant research report of punctuation information, based on the statistical caliber of the product registration certificate, there are currently about 370 manufacturers in the domestic orthopedic medical device market, of which about 270 are domestic enterprises.
The overall competition pattern is relatively scattered.
The overall competition pattern is relatively scattered.
Looking at industry changes from the development direction of medical insurance
Looking at industry changes from the development direction of medical insurance In the medical industry with three-medicine linkage, the first link of medicine belongs to the supplier, providing drugs and medical equipment, the hospital belongs to the provider of medical services, and the patient and medical insurance are the payers, and the medical insurance is responsible for most of the expenses as a whole.
Many hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Hospital hospital hospitalMany hospital insiders have stated that medical insurance payments in many hospitals account for more than 65% of annual income.
Therefore, the development direction of medical insurance will directly affect the overall development direction of the industry.
Hu Jinglin published the above-mentioned article in the "Learning Times" and stated that to promote the high-quality development of medical insurance, this is a process from extensive expansionary development to quality and efficiency development.
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The basic connotation of the high-quality development of medical insurance can be summarized as "five changes".
The first is to be more fair, emphasizing the promotion of common prosperity, so that all people can share the fruits of development;
The second is to be more efficient, emphasizing improving the efficiency of fund use, and attaching importance to the input-output ratio;
The third is more sustainable, emphasizing continuous and stable protection of the basic health rights of the people, and the system and funds can maintain their own balance in the medium and long term;
The fourth is to be more secure, emphasizing the positioning of the basic system of social security, safeguarding the fundamental interests of the broadest masses of people, coordinating the advancement of medical insurance and medical development, ensuring the safe operation of funds and timely payment of benefits, etc.
;
;
Fifth, it is more convenient, emphasizing reducing the waiting time and cost of mass business processing.
On March 8th, the National Medical Insurance Administration issued the "Statistical Bulletin of Medical Security Development in 2020".
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
The total income and total expenditure of the basic medical insurance fund for the year were 2.
463861 billion yuan and 2.
094926 billion yuan, respectively.
The cumulative balance of basic medical insurance at the end of the year was 3.
137338 billion yuan.
.
Among them, the annual employee basic medical insurance fund income was 1,562.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
461 billion yuan, a year-on-year decrease of 1.
4%; of which, the collection income was 1,479.
647 billion yuan.
Fund expenditures were 1,283.
399 billion yuan, a year-on-year increase of 1.
3%.
Researchers from the Chinese Academy of Labor and Social Security Sciences published an article analysis in "China Medical Insurance" that the income of the employee medical insurance fund fell by 1.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
4% year-on-year.
This is the first time in many years that employee medical insurance has experienced a decline in fund income.
It is an abnormal phenomenon in the event of a major epidemic.
The main factor is the adjustment of the payment policy in response to the epidemic.
The above-mentioned researchers further analyzed that in the past year, regardless of whether the employee medical insurance or the resident medical insurance, the growth of fund expenditures has shown a new situation that is very different from that of previous years.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
Fund expenditures may increase slightly or decrease slightly, and the growth rate in previous years has been above double digits.
The slight increase or slight decrease in medical insurance fund expenditures in 2020 is closely related to the new crown epidemic greatly reducing the demand for medical treatment.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
However, the reduction in medical treatment has not affected the health of residents.
The special situation in this special period also objectively reflects from one aspect.
In the past, there was indeed a large proportion of unnecessary and unreasonable medical treatment, and there was indeed a large waste of medical insurance funds.
This requires that the reform of medical insurance payment methods in the future still needs to be accelerated, and fund supervision needs to be strengthened to continue to squeeze out a large amount of medical expenses and further improve the efficiency of the use of medical insurance funds.
